The portfolio is heavily weighted towards common stocks, with a significant portion allocated to Checkpoint Therapeutics Inc. Funds such as the Fidelity Flex 500 Index Fund and Fidelity Flex International Index Fund provide some balance. Compared to common benchmarks, this portfolio skews heavily towards individual stock holdings. This composition reflects a speculative approach, focusing on high-risk, potentially high-reward investments. To reduce risk, consider increasing exposure to diversified funds or other asset classes.
With a CAGR of 4.39%, the portfolio's historic performance is modest, particularly given its speculative nature. A concerning max drawdown of -57.86% highlights significant volatility. For context, standard benchmarks often exhibit lower drawdowns. This suggests that while the portfolio has growth potential, it is prone to substantial losses. To enhance stability, consider rebalancing towards more stable, diversified assets that may offer consistent returns.
Monte Carlo simulations, which use historical data to project future outcomes, show a bleak outlook with negative returns in most scenarios. This highlights the limitations of relying solely on past data, as it does not guarantee future results. The simulations suggest a high risk of capital loss. Exploring alternative asset allocations or rebalancing strategies could improve future projections and reduce downside risk.
The portfolio is overwhelmingly composed of stocks, with minimal allocation to other asset classes. This lack of diversity can increase vulnerability to market swings. In contrast, benchmark portfolios often include bonds and other asset classes to mitigate risk. Introducing a mix of asset classes, such as bonds or real estate, could enhance diversification and provide a buffer against stock market volatility.
The portfolio shows a strong concentration in healthcare and technology sectors, which can lead to higher volatility during market shifts. Compared to benchmarks, this concentration suggests an aggressive growth strategy. While these sectors offer growth potential, diversifying into other sectors could reduce risk and improve stability. Consider gradually reallocating funds to underrepresented sectors for better balance.
Geographic exposure is heavily tilted towards North America, with limited diversification internationally. This overexposure to one region can increase vulnerability to regional economic downturns. Benchmarks typically have more balanced geographic allocations. Expanding exposure to international markets could enhance diversification and reduce regional risk, potentially improving long-term performance.
This chart shows the Efficient Frontier, calculated using your current assets with different allocation combinations. It highlights the best balance between risk and return based on historical data. "Efficient" portfolios maximize returns for a given risk or minimize risk for a given return. Portfolios below the curve are less efficient. This is informational and not a recommendation to buy or sell any assets.
Click on the colored dots to explore allocations.
The portfolio could be optimized using the Efficient Frontier, which illustrates the best possible risk-return ratio for a given level of risk. Current allocations may not fully exploit potential returns. Adjusting the asset mix to achieve a more efficient portfolio could significantly enhance expected returns without increasing risk. Consider consulting with a financial advisor for tailored optimization strategies.
The portfolio's overall dividend yield is low, at 0.52%, with contributions mainly from index funds. Dividends can provide a steady income stream and cushion against market volatility. For investors seeking income, increasing exposure to higher-yielding assets could be beneficial. Consider adding dividend-focused funds or stocks to enhance the portfolio’s income potential.
Select a broker that fits your needs and watch for low fees to maximize your returns.
The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.
Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.
Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.
Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.
By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.
Instrument logos provided by Elbstream.
Your feedback makes a difference! Share your thoughts in our quick survey. Take the survey